← Back to Search

Triamcinolone Acetonide 40mg/mL for Retinal Detachment

Phase 4
Waitlist Available
Led By Vishak J John, MD
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day post-op
Awards & highlights

Study Summary

This trial is testing whether sub-tenon's irrigation with triamcinolone acetonide at the time of surgery can reduce pain, nausea/vomiting, and analgesic use caused by scleral buckle surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cumulative amount used was assessed at one week after operation
This trial's timeline: 3 weeks for screening, Varies for treatment, and cumulative amount used was assessed at one week after operation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post Operative Pain Day 1
Secondary outcome measures
Pain Medication Use (Tylenol in mg)
Pain Medication Use Week 1
Post Operative Pain Week 1

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental (Triamcinolone Acetonide)Experimental Treatment1 Intervention
receives a sub-tenon irrigation of 1 cc 40mg/mL triamcinolone acetonide around the base of the scleral buckle (0.25 cc in each quadrant) at time of operation
Group II: ControlActive Control1 Intervention
No additional drug given
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Triamcinolone Acetonide 40mg/mL
2020
Completed Phase 4
~280

Find a Location

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor
142 Previous Clinical Trials
27,743 Total Patients Enrolled
Vishak J John, MDPrincipal InvestigatorVirginia Tech, Vistar Eye Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has Triamcinolone Acetonide 40mg/mL earned the endorsement of the FDA?

"There is ample evidence of Triamcinolone Acetonide 40mg/mL's safety due to its Phase 4 status, thus it was given a rating of 3."

Answered by AI

What therapeutic purposes do practitioners typically employ Triamcinolone Acetonide 40mg/mL for?

"Triamcinolone Acetonide 40mg/mL has been utilized to manage cases of ulcerative colitis, hand-related afflictions and brain related conditions."

Answered by AI

Could you enumerate any other tests that have been done involving Triamcinolone Acetonide 40mg/mL?

"Currently, 8 trials of Triamcinolone Acetonide 40mg/mL are in their final stages with 41 studies still active. The majority of these clinical tests take place in Columbia, Missouri; however, a total of 75 locations across the nation have launched studies on this medication."

Answered by AI

Is it feasible to enroll in this research program presently?

"Affirmative. Per the data on clinicaltrials.gov, this trial is currently seeking volunteers who meet its criteria. It was first advertised on March 1st 2020 and has been updated most recently as of February 15th 2022; it aims to recruit 24 people from a single site for participation in this study."

Answered by AI

What is the aggregate number of participants partaking in this research?

"Affirmative. Clinicaltrials.gov lists this trial as actively enrolling patients with a start date of 3 January 2020 and last updated on 15 February 2022. It is seeking 24 individuals at one location for participation in the study."

Answered by AI
~3 spots leftby Apr 2025